November 15, 2010 — A new exclusive worldwide license has been executed for patented technology for a proprietary brachytherapy seed with a fast-dissolving matrix for optimized delivery of radionuclides to cancer tissue.

The resorbable seed, from Advanced Medical Isotope Corp., provides controlled delivery of insoluble yttrium-90 microspheres. The new seed is a joint invention by radiochemists and medical physicists at Battelle in Richland, Wash., and pharmaceutical chemists at the University of Utah in Salt Lake City. AMIC is testing and conducting research to develop the new brachytherapy seed. It planned to file premarket notification (510k) with the U.S. Food and Drug Administration (FDA) in October.

Yttrium-90 is a high-energy beta-emitting medical isotope with good potential for treating highly localized cancer, AMIC says. The company anticipates the use of these seeds for prostate cancer as well as for many of the more radiation-resistant cancers, such as brain tumors, head and neck tumors and liver cancer. The resorbable seeds resemble conventional metal brachytherapy seeds and may be placed by direct injection using standard needles, grids and imaging systems. However, AMIC expects that the technology should enable seed manufacturing at lower cost relative to conventional welded-metal seeds.

Unlike current seeds, yttrium-90 decays with a shorter physical half-life (2.7 days) with negligible radiation outside the patient. The shorter half-life also suggests a potentially higher biological effective dose (BED) value for cancer cell destruction.

The insoluble form of the yttrium-90 microspheres effectively confines the radioactivity to the injection site and limits potential dissolution into blood.

For more information: www.isotopeworld.com

Related Content

News | PET Imaging

October 18, 2021 — PSMA (prostate-specific membrane antigen) PET/CT is more accurate than conventional CT in the ...

Time October 18, 2021
arrow
News | Radiographic Fluoroscopy (RF)

October 18, 2021 — Long Island Jewish Valley Stream of Valley Stream, N.Y., recently became the first healthcare ...

Time October 18, 2021
arrow
News | Ultrasound Imaging

October 15, 2021 — NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, introduces the V8; a high-end ...

Time October 15, 2021
arrow
News | Computed Tomography (CT)

October 14, 2021 — Cardiac computed tomography angiography (CTA) derived left atrium emptying fraction (LAEF) improves ...

Time October 14, 2021
arrow
News | Ultrasound Women's Health

October 14, 2021 — In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto ...

Time October 14, 2021
arrow
News | Radiology Business

October 14, 2021 — Intelerad Medical Systems, a global leader in medical image management solutions, today announced its ...

Time October 14, 2021
arrow
News | Lung Imaging

October 11, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), percutaneous image-guided microwave and ...

Time October 11, 2021
arrow
News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Women's Health

October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S ...

Time October 08, 2021
arrow
News | Radiology Business

October 8, 2021 — Commonwealth Radiology Associates (CRA) is the largest private practice radiology group in ...

Time October 08, 2021
arrow
Subscribe Now